Shilpa Medicare announced that its wholly-owned material subsidiary, Shilpa Pharma Lifesciences, has fully redeemed its outstanding senior, secured, rated, unlisted, and redeemable Non-Convertible Debentures (NCDs) on 11 August 2025.
Accordingly, there are no outstanding NCDs as on date with Shilpa Pharma Lifesciences.